Table 6.

Comparison of the cumulative days of each symptom during the intake period (young participants).

Symptoms	Group	1–4 W			1–8 W			1–12 W
		Without	With	p-value	Without	With	p-value	Without	With	p-value
Runny nose	Placebo	702	194	0.043*	1,379	413	0.007*	2,115	573	0.053
	LG2055	646	138		1,267	301		1,903	449
Nasal congestion	Placebo	738	158	0.128	1,476	316	0.180	2,229	459	0.910
	LG2055	668	116		1,319	249		1,954	398
Sneezing	Placebo	815	81	0.323	1,540	252	1.000	2,270	418	0.667
	LG2055	701	83		1,348	220		1,997	355
Sore throat	Placebo	734	162	<0.001*	1,498	294	<0.001*	2,281	407	<0.001*
	LG2055	692	92		1,376	192		2,085	267
Hoarseness	Placebo	796	100	<0.001*	1,596	196	<0.001*	2,398	290	<0.001*
	LG2055	734	50		1,454	114		2,199	153
Cough	Placebo	813	83	0.131	1,633	159	0.148	2,452	236	0.006*
	LG2055	728	56		1,451	117		2,195	157
Headache	Placebo	804	92	<0.001*	1,616	176	<0.001*	2,440	248	<0.001*
	LG2055	750	34		1,494	74		2,253	99
General malaise	Placebo	775	121	0.001*	1,555	237	0.005*	2,361	327	<0.001*
	LG2055	717	67		1,410	158		2,135	217
Chills	Placebo	833	63	0.001*	1,670	122	<0.001*	2,537	151	<0.001*
	LG2055	757	27		1,512	56		2,285	67
Feverishness	Placebo	854	42	0.008*	1,695	97	<0.001*	2,559	129	<0.001*
	LG2055	766	18		1,532	36		2,308	44
Fatigue	Placebo	740	156	0.144	1,521	271	0.599	2,320	368	0.137
	LG2055	669	115		1,320	248		1,995	357
Feeling unwell	Placebo	845	51	<0.001*	1,691	101	<0.001*	2,550	138	<0.001*
	LG2055	769	15		1,531	37		2,297	55

^*Significant difference between the two groups (p < 0.05).